Hennepin Healthcare   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Minneapolis MN United States (1887)

Organization Overview

First Clinical Trial
1993
NCT00004266
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Gaylan Rockswold | Hennepin County Medical Canter | Hennepin County Medical Center, Minneapolis | Hennepin County Medical Center/MinneapolisMRF | Hennepin Faculty Associates | Hennepin Health Care | Hennepin Healthcare Research Institute | Hennepin Healthcare Research Institute. | Hennepin Heatlhcare | Jason Baker | Jon B Cole | Minneapolis Medical Research Foundation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Abdominal Pain (Phase 4)

Alcoholism (Phase 2)

Brain Injuries (Phase 4)

Brain Injuries, Traumatic (Phase 4)

Chronic Pain (Phase 2)

Diabetes Mellitus (Phase 4)

Disease (Phase 3)

Emergencies (Phase 4)

Fibrosis (Phase 2)

Heart Failure (Phase 1)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis, Alcoholic (Phase 2)

HIV Infections (Phase 4)

Inflammation (Phase 2)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 2)

Neonatal Abstinence Syndrome (Phase 4)

Opioid-Related Disorders (Phase 2)

Proteinuria (Phase 4)

Psychomotor Agitation (Phase 4)

Renal Colic (Phase 4)

Sleep Initiation and Maintenance Disorders (Phase 3)

Substance-Related Disorders (Phase 4)

Syndrome (Phase 4)

Thrombosis (Phase 4)

Venous Thrombosis (Phase 4)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 39
  • # of Trial APIs: 37